Scientists unveil new obesity drug that reprograms fat and energy use
Details of a new drug that aims to treat the underlying causes of obesity are being presented at…
Ionis gets approval for preventing attacks in rare and genetic HAE
In Ionis Pharmaceuticals Inc.’s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as…
Breakthroughs in diagnosis and therapy for transthyretin amyloidosis
Transthyretin amyloidosis (ATTR) is caused by the misfolding and aggregation of the transthyretin (TTR) protein, leading to multi-organ…